isoproterenol has been researched along with hmr 1556 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beekman, JD; Gerlach, U; Sipido, KR; Spätjens, RL; Stengl, M; van Opstal, JM; Volders, PG; Vos, MA | 1 |
Dong, MQ; Gao, Z; Lau, CP; Li, GR; Tseng, GN | 1 |
Antoons, G; Donker, DW; Moorman, AF; Nabar, A; Ramakers, C; Rybin, AV; Sipido, KR; Spätjens, RL; Stengl, M; van der Nagel, T; Volders, PG; Vos, MA; Wodzig, WK | 1 |
Backx, PH; Dorian, P; Hu, XD; So, PP | 1 |
Gallacher, DJ; Hermans, AN; Lu, HR; Towart, R; Van de Water, A; van der Linde, H; Volders, PG | 1 |
Bányász, T; Bárándi, L; Farkas, V; Hegyi, B; Horváth, B; Magyar, J; Márton, I; Nánási, PP; Ruzsnavszky, F; Szentandrássy, N | 1 |
Bányász, T; Hegyi, B; Horváth, B; Kistamás, K; Magyar, J; Nánási, PP; Ruzsnavszky, F; Szentandrássy, N; Váczi, K; Varró, A | 1 |
7 other study(ies) available for isoproterenol and hmr 1556
Article | Year |
---|---|
Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation.
Topics: Adrenergic beta-Agonists; Anilides; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Chromans; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Ventricles; Isoproterenol; Myocytes, Cardiac; Potassium Channel Blockers; Potassium Channels; Propanolamines; Receptors, Adrenergic, beta; Sulfonamides; Ventricular Function; Wakefulness | 2003 |
Characterization of recombinant human cardiac KCNQ1/KCNE1 channels (I (Ks)) stably expressed in HEK 293 cells.
Topics: Action Potentials; Adrenergic beta-Agonists; Barium; Cells, Cultured; Chromans; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Humans; Isoproterenol; Isoquinolines; KCNQ1 Potassium Channel; Kidney; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Kinase Inhibitors; Recombinant Proteins; Sulfonamides; Transfection | 2006 |
Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Blotting, Western; Chromans; Dogs; Down-Regulation; Electrocardiography; Epinephrine; Female; Heart Block; Hypertrophy, Left Ventricular; Isoproterenol; KCNQ1 Potassium Channel; Male; Membrane Potentials; Myocardium; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Receptors, Adrenergic, beta-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors | 2006 |
I(Ks) block by HMR 1556 lowers ventricular defibrillation threshold and reverses the repolarization shortening by isoproterenol without rate-dependence in rabbits.
Topics: Action Potentials; Animals; Chromans; Delayed Rectifier Potassium Channels; Electric Countershock; In Vitro Techniques; Isoproterenol; Male; Rabbits; Sulfonamides; Ventricular Fibrillation | 2007 |
In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium; Chromans; Disease Models, Animal; Dogs; Female; Isoproterenol; Long QT Syndrome; Male; Reproducibility of Results; Sulfonamides; Torsades de Pointes | 2007 |
Role of action potential configuration and the contribution of C²⁺a and K⁺ currents to isoprenaline-induced changes in canine ventricular cells.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; Chromans; Delayed Rectifier Potassium Channels; Dogs; Female; Isoproterenol; Male; Myocytes, Cardiac; Nisoldipine; Patch-Clamp Techniques; Piperidines; Pyridines; Sulfonamides | 2012 |
Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Chromans; Dogs; Feedback, Physiological; Female; Heart Ventricles; Ion Channels; Ion Transport; Isoproterenol; Lidocaine; Male; Myocytes, Cardiac; Nisoldipine; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Tetrodotoxin; Veratridine | 2015 |